Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A - Asset Resilience Ratio

Latest as of September 2025: 6.83%

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (600613) has an Asset Resilience Ratio of 6.83% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Shanghai Shenqi Pharmaceutical Investmen for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥210.65 Million
≈ $30.83 Million USD Cash + Short-term Investments

Total Assets

CN¥3.09 Billion
≈ $451.61 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1993–2024)

This chart shows how Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's Asset Resilience Ratio has changed over time. See Shanghai Shenqi Pharmaceutical Investmen (600613) net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600613 company net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥210.65 Million 6.83%
Total Liquid Assets CN¥210.65 Million 6.83%

Asset Resilience Insights

  • Limited Liquidity: Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A maintains only 6.83% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A Industry Peers by Asset Resilience Ratio

Compare Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.09%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Novartis AG
SW:NOVN
Drug Manufacturers - General 10.04%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 7.18%
Firebrick Pharma Ltd
AU:FRE
Drug Manufacturers - General 0.29%
Eli Lilly and Company
SA:LILY34
Drug Manufacturers - General 8.63%
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3
Drug Manufacturers - General 10.10%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436
Drug Manufacturers - General 17.40%

Annual Asset Resilience Ratio for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A (1993–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 0.67% CN¥20.87 Million
≈ $3.05 Million
CN¥3.12 Billion
≈ $455.94 Million
+0.03pp
2023-12-31 0.64% CN¥20.90 Million
≈ $3.06 Million
CN¥3.28 Billion
≈ $479.87 Million
+0.56pp
2008-12-31 0.08% CN¥200.00K
≈ $29.27K
CN¥261.87 Million
≈ $38.32 Million
-0.13pp
2005-12-31 0.20% CN¥595.54K
≈ $87.15K
CN¥294.59 Million
≈ $43.11 Million
+0.17pp
2000-12-31 0.03% CN¥151.55K
≈ $22.18K
CN¥530.13 Million
≈ $77.57 Million
-0.01pp
1999-12-31 0.04% CN¥184.97K
≈ $27.07K
CN¥486.20 Million
≈ $71.15 Million
+0.03pp
1998-12-31 0.01% CN¥91.55K
≈ $13.40K
CN¥747.54 Million
≈ $109.39 Million
0.00pp
1997-12-31 0.02% CN¥91.55K
≈ $13.40K
CN¥576.22 Million
≈ $84.32 Million
-0.20pp
1996-12-31 0.22% CN¥1.12 Million
≈ $163.97K
CN¥518.43 Million
≈ $75.86 Million
-1.34pp
1995-12-31 1.56% CN¥7.62 Million
≈ $1.12 Million
CN¥489.14 Million
≈ $71.58 Million
+1.35pp
1994-12-31 0.21% CN¥1.02 Million
≈ $149.11K
CN¥485.73 Million
≈ $71.08 Million
-2.86pp
1993-12-31 3.07% CN¥12.93 Million
≈ $1.89 Million
CN¥420.63 Million
≈ $61.55 Million
--
pp = percentage points

About Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A

SHG:600613 China Drug Manufacturers - General
Market Cap
$408.91 Million
CN¥2.79 Billion CNY
Market Cap Rank
#13611 Global
#4279 in China
Share Price
CN¥5.83
Change (1 day)
-0.85%
52-Week Range
CN¥5.45 - CN¥7.19
All Time High
CN¥24.35
About

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fiel… Read more